Liga Riccardo, Gimelli Alessia
Azienda Ospedaliero-Universitaria Pisana and University of Pisa, Pisa, Italy.
Imaging Department, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
Curr Cardiovasc Imaging Rep. 2022;15(3):23-28. doi: 10.1007/s12410-022-09565-x. Epub 2022 May 28.
The present review will outline the main effects of COVID-19 pandemic on cardiovascular pathologies, focusing on the role of modern non-invasive cardiac imaging techniques in this setting.
Multimodality cardiac imaging seems particularly suited for the in-depth characterization of patients with COVID-19, allowing the assessment of the variegated impact of the disease on the different aspects of myocardial perfusion, structure, and function.
The infection of SARS-CoV-2, leading to the coronavirus disease-19 (COVID-19), has represented a consistent challenge for the organization of the healthcare systems, associating to a significant increase of the fatality rate of different acute and chronic disease. Moreover, the reallocation of healthcare providers led to a significant reduction of the availability of tests and therapies, with the deferral of non-urgent tests and non-lifesaving procedures.
本综述将概述新冠疫情对心血管疾病的主要影响,重点关注现代无创心脏成像技术在这种情况下的作用。
多模态心脏成像似乎特别适合深入表征新冠患者,能够评估该疾病对心肌灌注、结构和功能不同方面的多样影响。
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染导致冠状病毒病-19(COVID-19),对医疗系统的组织构成了持续挑战,同时不同急慢性疾病的死亡率显著上升。此外,医疗服务提供者的重新调配导致检测和治疗的可及性大幅降低,非紧急检测和非救生程序被推迟。